BR112012012539B8 - derivados de ortoéster de éteres de coroa e composição farmacêutica ou de diagnóstico que os compreende - Google Patents
derivados de ortoéster de éteres de coroa e composição farmacêutica ou de diagnóstico que os compreendeInfo
- Publication number
- BR112012012539B8 BR112012012539B8 BR112012012539A BR112012012539A BR112012012539B8 BR 112012012539 B8 BR112012012539 B8 BR 112012012539B8 BR 112012012539 A BR112012012539 A BR 112012012539A BR 112012012539 A BR112012012539 A BR 112012012539A BR 112012012539 B8 BR112012012539 B8 BR 112012012539B8
- Authority
- BR
- Brazil
- Prior art keywords
- pharmaceutical
- crown ether
- diagnostic composition
- formula
- orthoester derivatives
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D323/00—Heterocyclic compounds containing more than two oxygen atoms as the only ring hetero atoms
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D493/00—Heterocyclic compounds containing oxygen atoms as the only ring hetero atoms in the condensed system
- C07D493/02—Heterocyclic compounds containing oxygen atoms as the only ring hetero atoms in the condensed system in which the condensed system contains two hetero rings
- C07D493/10—Spiro-condensed systems
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D493/00—Heterocyclic compounds containing oxygen atoms as the only ring hetero atoms in the condensed system
- C07D493/12—Heterocyclic compounds containing oxygen atoms as the only ring hetero atoms in the condensed system in which the condensed system contains three hetero rings
- C07D493/20—Spiro-condensed systems
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D495/00—Heterocyclic compounds containing in the condensed system at least one hetero ring having sulfur atoms as the only ring hetero atoms
- C07D495/02—Heterocyclic compounds containing in the condensed system at least one hetero ring having sulfur atoms as the only ring hetero atoms in which the condensed system contains two hetero rings
- C07D495/10—Spiro-condensed systems
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Medicinal Preparation (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Heterocyclic Compounds That Contain Two Or More Ring Oxygen Atoms (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Heterocyclic Carbon Compounds Containing A Hetero Ring Having Oxygen Or Sulfur (AREA)
- Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
- Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| EP09014693.7 | 2009-11-25 | ||
| EP09014693A EP2332929A1 (en) | 2009-11-25 | 2009-11-25 | Orthoester derivatives of crown ethers as carriers for pharmaceutical and diagnostic compositions |
| PCT/EP2010/068224 WO2011064300A1 (en) | 2009-11-25 | 2010-11-25 | Orthoester derivatives of crown ethers as carriers for pharmaceutical and diagnostic compositions |
Publications (3)
| Publication Number | Publication Date |
|---|---|
| BR112012012539A2 BR112012012539A2 (pt) | 2016-05-03 |
| BR112012012539B1 BR112012012539B1 (pt) | 2021-05-11 |
| BR112012012539B8 true BR112012012539B8 (pt) | 2021-05-25 |
Family
ID=42101959
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| BR112012012539A BR112012012539B8 (pt) | 2009-11-25 | 2010-11-25 | derivados de ortoéster de éteres de coroa e composição farmacêutica ou de diagnóstico que os compreende |
Country Status (10)
| Country | Link |
|---|---|
| US (1) | US8624044B2 (enExample) |
| EP (2) | EP2332929A1 (enExample) |
| JP (1) | JP5848708B2 (enExample) |
| CN (1) | CN102770421B (enExample) |
| AU (1) | AU2010323101B2 (enExample) |
| BR (1) | BR112012012539B8 (enExample) |
| CA (1) | CA2783306C (enExample) |
| ES (1) | ES2557916T3 (enExample) |
| IL (1) | IL219966A (enExample) |
| WO (1) | WO2011064300A1 (enExample) |
Families Citing this family (4)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| WO2011064316A2 (en) | 2009-11-25 | 2011-06-03 | Paolo Botti | Mucosal delivery of peptides |
| EP2526971A1 (en) * | 2011-05-25 | 2012-11-28 | ArisGen SA | Mucosal delivery of drugs |
| EP3000811B1 (en) | 2014-09-24 | 2017-11-08 | Friedrich-Alexander-Universität Erlangen-Nürnberg | Crown Ether Complexes and Methods for Poducing the Same |
| JP7480132B2 (ja) * | 2018-10-12 | 2024-05-09 | アドヴァンスド アクセラレーター アプリケーションズ インターナショナル エセ．アー． | 放射性標識されたｇｐｒｐアンタゴニスト及び界面活性剤を含む医薬組成物 |
Family Cites Families (6)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US4113739A (en) * | 1974-01-28 | 1978-09-12 | The Dow Chemical Company | Process for preparation of (poly)cyclic polyethers |
| US4474963A (en) * | 1980-11-03 | 1984-10-02 | W. R. Grace & Co. | Crown ether compositions with sidearms affording enhanced cation binding |
| GB8607679D0 (en) | 1986-03-27 | 1986-04-30 | Winter G P | Recombinant dna product |
| IL162181A (en) | 1988-12-28 | 2006-04-10 | Pdl Biopharma Inc | A method of producing humanized immunoglubulin, and polynucleotides encoding the same |
| US5849535A (en) | 1995-09-21 | 1998-12-15 | Genentech, Inc. | Human growth hormone variants |
| EP1905454A1 (en) * | 2006-09-27 | 2008-04-02 | Paolo Botti | Formulations comprising cyclic compounds |
-
2009
- 2009-11-25 EP EP09014693A patent/EP2332929A1/en not_active Withdrawn
-
2010
- 2010-11-25 JP JP2012540429A patent/JP5848708B2/ja not_active Expired - Fee Related
- 2010-11-25 ES ES10784504.2T patent/ES2557916T3/es active Active
- 2010-11-25 US US13/511,837 patent/US8624044B2/en not_active Expired - Fee Related
- 2010-11-25 EP EP10784504.2A patent/EP2504327B1/en not_active Not-in-force
- 2010-11-25 CN CN201080062354.9A patent/CN102770421B/zh not_active Expired - Fee Related
- 2010-11-25 WO PCT/EP2010/068224 patent/WO2011064300A1/en not_active Ceased
- 2010-11-25 BR BR112012012539A patent/BR112012012539B8/pt not_active IP Right Cessation
- 2010-11-25 CA CA2783306A patent/CA2783306C/en active Active
- 2010-11-25 AU AU2010323101A patent/AU2010323101B2/en not_active Ceased
-
2012
- 2012-05-23 IL IL219966A patent/IL219966A/en active IP Right Grant
Also Published As
| Publication number | Publication date |
|---|---|
| CA2783306A1 (en) | 2011-06-03 |
| EP2332929A1 (en) | 2011-06-15 |
| AU2010323101B2 (en) | 2014-10-02 |
| CN102770421A (zh) | 2012-11-07 |
| BR112012012539A2 (pt) | 2016-05-03 |
| IL219966A0 (en) | 2012-07-31 |
| WO2011064300A1 (en) | 2011-06-03 |
| EP2504327A1 (en) | 2012-10-03 |
| CA2783306C (en) | 2021-01-19 |
| AU2010323101A1 (en) | 2012-06-07 |
| BR112012012539B1 (pt) | 2021-05-11 |
| CN102770421B (zh) | 2014-11-26 |
| EP2504327B1 (en) | 2015-07-29 |
| JP2013512221A (ja) | 2013-04-11 |
| US20120301401A1 (en) | 2012-11-29 |
| IL219966A (en) | 2014-12-31 |
| US8624044B2 (en) | 2014-01-07 |
| ES2557916T3 (es) | 2016-01-29 |
| JP5848708B2 (ja) | 2016-01-27 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| BRPI0910388A2 (pt) | agentes terapêutico antivirais. | |
| GT200800189A (es) | Derivados de amida y su aplicación para el tratamiento de enfermedades relacionadas con proteína-g | |
| DOP2010000229A (es) | Compuestos que comprenden un grupo ciclobutoxi | |
| ECSP088623A (es) | Derivados de azepinoindol como agentes farmacéuticos | |
| CO6351783A2 (es) | Derivados de indazoles sustituidos con fenilo o piridinilo | |
| CY1118048T1 (el) | Αντι-ιικες ενωσεις | |
| BR112012033350A2 (pt) | "composição e métodos para modular a via de sinalização de wnt" | |
| CR20120264A (es) | Compuestos | |
| UY33735A (es) | Compuestos antivirales | |
| BR112012004335A8 (pt) | Composto, composição farmacêutica, e, uso do composto. | |
| UY32648A (es) | Nuevos derivados de pirimidina y su uso en el tratamiento de enfermedades | |
| ECSP10010095A (es) | 2'-fluoro-2'-desoxitetrahidrouridinas como inhibidores de citidina desaminasa | |
| MX2011011797A (es) | Fenilureas y fenilamidas sustituidas como ligandos del receptor de vanilloides. | |
| EA200971140A1 (ru) | Триарильные соединения и композиции, их содержащие | |
| BR112014031292A2 (pt) | sistema cristalino de múltiplos componentes, processo para obter a composição cristalina, e, composição farmacêutica | |
| CO6630184A2 (es) | Formulaciones famacéuticas que comprenden derivados de 1 (beta-d-glucopiranosil)-2-tienil-metilbenceno como inhibidores de sglt | |
| UY32744A (es) | Derivados de 2-carboxamida-7-piperazinil-benzofurano 774 | |
| BRPI1014802B8 (pt) | profármacos de triptolida. | |
| BRPI0607309A2 (pt) | processos para a preparação de fenilpirazol uréias substituìdas | |
| UY29839A1 (es) | Ácidos fenoxiaceticos sustituidos, composiciones farmacéuticas conteniéndolos, procesos para su preparación y aplicaciones. | |
| SV2011003944A (es) | Antagonistas de 4-azetidinil-1-heteroaril-ciclohexano de ccr2 | |
| UA107455C2 (uk) | Похідні індолу як протиракові агенти | |
| SV2009003429A (es) | Derivados de 7-alquinil-1,8-naftiridonas, su preparacion y su aplicacion en terapeutica | |
| CO6321288A2 (es) | Sales de compuestos inhibidores de vih | |
| ECSP109961A (es) | Derivados de indol-2-ona disustituidos en 3, su preparación y su aplicación en terapéutica |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| B06F | Objections, documents and/or translations needed after an examination request according [chapter 6.6 patent gazette] | ||
| B07D | Technical examination (opinion) related to article 229 of industrial property law [chapter 7.4 patent gazette] |
Free format text: DE ACORDO COM O ARTIGO 229-C DA LEI NO 10196/2001, QUE MODIFICOU A LEI NO 9279/96, A CONCESSAO DA PATENTE ESTA CONDICIONADA A ANUENCIA PREVIA DA ANVISA. CONSIDERANDO A APROVACAO DOS TERMOS DO PARECER NO 337/PGF/EA/2010, BEM COMO A PORTARIA INTERMINISTERIAL NO 1065 DE 24/05/2012, ENCAMINHA-SE O PRESENTE PEDIDO PARA AS PROVIDENCIAS CABIVEIS. |
|
| B25A | Requested transfer of rights approved |
Owner name: PAOLO BOTTI (CH) |
|
| B25A | Requested transfer of rights approved |
Owner name: CAPSUGEL BELGIUM NV (BE) |
|
| B07E | Notification of approval relating to section 229 industrial property law [chapter 7.5 patent gazette] | ||
| B06U | Preliminary requirement: requests with searches performed by other patent offices: procedure suspended [chapter 6.21 patent gazette] | ||
| B06A | Patent application procedure suspended [chapter 6.1 patent gazette] | ||
| B09A | Decision: intention to grant [chapter 9.1 patent gazette] | ||
| B16A | Patent or certificate of addition of invention granted [chapter 16.1 patent gazette] |
Free format text: PRAZO DE VALIDADE: 20 (VINTE) ANOS CONTADOS A PARTIR DE 25/11/2010, OBSERVADAS AS CONDICOES LEGAIS. PATENTE CONCEDIDA CONFORME MEDIDA CAUTELAR DE 07/04/2021 - ADI 5.529/DF |
|
| B16C | Correction of notification of the grant [chapter 16.3 patent gazette] |
Free format text: PRAZO DE VALIDADE: 20 (VINTE) ANOS CONTADOS A PARTIR DE 25/11/2010 OBSERVADAS AS CONDICOES LEGAIS. PATENTE CONCEDIDA CONFORME ADI 5.529/DF |
|
| B21F | Lapse acc. art. 78, item iv - on non-payment of the annual fees in time |
Free format text: REFERENTE A 14A ANUIDADE. |
|
| B24J | Lapse because of non-payment of annual fees (definitively: art 78 iv lpi, resolution 113/2013 art. 12) |
Free format text: EM VIRTUDE DA EXTINCAO PUBLICADA NA RPI 2802 DE 17-09-2024 E CONSIDERANDO AUSENCIA DE MANIFESTACAO DENTRO DOS PRAZOS LEGAIS, INFORMO QUE CABE SER MANTIDA A EXTINCAO DA PATENTE E SEUS CERTIFICADOS, CONFORME O DISPOSTO NO ARTIGO 12, DA RESOLUCAO 113/2013. |